Catalysts for Hikma Pharmaceuticals Plc
852 tracked
Oct 18, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Aug 31, 2023
approval
ALVIMOPAN — FDA approval
ALVIMOPAN
→
Jul 17, 2023
approval
MEPERIDINE HYDROCHLORIDE — FDA approval
Hikma Pharmaceuticals Plc
→
Jul 17, 2023
approval
MEPERIDINE HYDROCHLORIDE — FDA approval
Hikma Pharmaceuticals Plc
→
Jul 17, 2023
approval
MEPERIDINE HYDROCHLORIDE — FDA approval
Hikma Pharmaceuticals Plc
→
Jun 6, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Mar 3, 2023
approval
FENTANYL CITRATE — FDA approval
Effentora
→
Jan 20, 2023
approval
FENTANYL CITRATE — FDA approval
Effentora
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Oct 12, 2022
approval
VIGABATRIN — FDA approval
VIGABATRIN
→
Sep 16, 2022
approval
LOSARTAN POTASSIUM — FDA approval
LOSARTAN POTASSIUM
→
Aug 29, 2022
approval
VIGABATRIN — FDA approval
VIGABATRIN
→
Jul 13, 2022
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 15, 2022
approval
EXEMESTANE — FDA approval
EXEMESTANE
→
Jun 14, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
May 3, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
May 3, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Apr 5, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Apr 5, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Nov 24, 2021
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jul 22, 2021
approval
MORPHINE SULFATE — FDA approval
Kapanol
→
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 2, 2021
approval
METHADONE HYDROCHLORIDE — FDA approval
METHADONE HYDROCHLORIDE
→
Jun 2, 2021
approval
METHADONE HYDROCHLORIDE — FDA approval
METHADONE HYDROCHLORIDE
→